Expertise in
1
conditions

Delphine Legoupil

CHU Rennes
Rennes, FR 
Expertise in
1
conditions
CHU Rennes
Rennes, FR 

Overview

Delphine Legoupil practices practicing medicine in Rennes, France.

Ms. Legoupil is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Melanoma, Pustules, Neuroendocrine Tumor, and Melasma.

She is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

CHU Rennes
Rennes, France
Other Locations
CHRU Brest
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Written Advice to Improve Compliance With Early Detection of Melanoma in First-degree Relatives: a Multicenter, Cluster-randomized Intervention Trial to Evaluate the Impact of Specific Incentives and Study Psychological Determinants of Early Melanoma Detection Behavior in First-degree Relatives
Written Advice to Improve Compliance With Early Detection of Melanoma in First-degree Relatives: a Multicenter, Cluster-randomized Intervention Trial to Evaluate the Impact of Specific Incentives and Study Psychological Determinants of Early Melanoma Detection Behavior in First-degree Relatives
Enrollment Status: Completed
Publish Date: December 30, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
Evaluation of Cobimetinib + Vemurafenib Combination Treatment in Patients With Brain Metastasis BRAFV600 Mutated Cutaneous Melanoma
Evaluation of Cobimetinib + Vemurafenib Combination Treatment in Patients With Brain Metastasis BRAFV600 Mutated Cutaneous Melanoma
Enrollment Status: Completed
Publish Date: January 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

47 Total Publications

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 22, 2025

Frequently Asked Questions about Delphine Legoupil

Is Delphine Legoupil a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Delphine Legoupil is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Delphine Legoupil participate in research or clinical trials?

Yes. Delphine Legoupil has published 47 articles and abstracts on conditions like Melanoma. You can view a list of Delphine Legoupil's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Legoupil's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile